Loading...
Market
Which Medicare drug will save the most in total costs for enrollees by end of 2026?
2
Resolution / Starting Odds
Drug A • 25%
Drug B • 25%
Drug C • 25%
Other • 25%
Official Medicare financial reports and statements, verified by reputable news sources.
Story
Biden Administration's Historic Deal to Cut Medicare Drug Prices by $6 Billion, Save Enrollees $1.5 Billion
Aug 15, 2024, 09:09 AM
The Biden administration has announced a historic agreement to reduce the prices of 10 of Medicare's most popular and costliest prescription drugs. This unprecedented negotiation, part of the Inflation Reduction Act, is expected to save the U.S. government $6 billion in 2026. Additionally, Medicare enrollees are projected to save $1.5 billion in out-of-pocket costs. The agreement involves reaching price deals with all manufacturers of the selected drugs, which collectively cost $50 billion annually. This initiative aims to alleviate financial burdens on older Americans, as Medicare covers 66 million people.
View original story
Similar markets
Eliquis • 25%
Jardiance • 25%
Xarelto • 25%
Other • 25%
Drug A • 25%
Drug B • 25%
Drug C • 25%
Other • 25%
Eliquis • 25%
Jardiance • 25%
Xarelto • 25%
Other • 25%
Drug A • 25%
Drug B • 25%
Drug C • 25%
Other • 25%
Less than $5 billion • 25%
$5 billion to $6 billion • 25%
$6 billion to $7 billion • 25%
More than $7 billion • 25%
Less than $6 billion • 25%
$6 billion to $7 billion • 25%
$7 billion to $8 billion • 25%
More than $8 billion • 25%
Less than 15% • 25%
15% to 20% • 25%
20% to 25% • 25%
More than 25% • 25%
Yes • 50%
No • 50%
Less than $1 billion • 25%
$1 billion to $1.5 billion • 25%
$1.5 billion to $2 billion • 25%
More than $2 billion • 25%
Less than $4 billion • 25%
$4 billion to $5 billion • 25%
$5 billion to $6 billion • 25%
More than $6 billion • 25%
Northeast • 25%
Midwest • 25%
South • 25%
West • 25%